HIV protease inhibitor (Bioavailability Systems)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameHIV protease inhibitor (Bioavailability Systems)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHIV protease inhibitors
TargetsHIV protease
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesBioavailability Systems LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioavailability Systems LLC
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A